Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Teitelbaum Law Group
- Klehr Harrison
- Consovoy McCarthy
- Sherrard Roe
- Phillips Lytle
- Porzio Bromberg
- Frost Brown
- Godfrey & Kahn
- Himes Petrarca
- Lowe Stein
- Terrell Hogan
- Spangenberg Shibley
- Potter Anderson
- Clifford Law Offices
- Gage Spencer & Fleming
- Motley Rice
- Pachulski Stang
- BatesCarey
- Keller Rohrback
- Kirkland & Ellis
- WilmerHale
- Gertz & Rosen
- Andrews & Thornton
- MoloLamken
- McElroy Deutsch
- Katsky Korins
- Binder & Schwartz
- Cleary Gottlieb
- Joseph Hage Aaronson
- ASK LLP
- Porteous Hainkel
- Ballard Spahr
- Cuneo Gilbert
- Pillsbury Winthrop
- Lite DePalma
- WestLoop Law
- Dechert LLP
- Pashman Stein
- Marino Tortorella
- Alston & Bird
- Slevin & Hart
- Cronin Fried
- Gilbert LLP
- King & Spalding
- Mehri & Skalet
- Squire Patton
- Troutman
- Dentons
- Caplin & Drysdale
- Blank Rome
- Crowell & Moring
- McGrail & Bensinger
- Doster Ullom
- Reed Smith
- Bentley & Bruning
- Porter Hedges
- Miller Nash LLP
- Brown & Connery
- Hurwitz Fine
- Miller Shah LLP
- Skadden Arps
- Lerner Arnold
- Kramer Levin
- Loeb & Loeb
- Morgan Lewis
- Bialson Bergen
- Shipman & Goodwin
- Bielli & Klauder
- Duane Morris
- Hagens Berman
- UB Greensfelder
- Faegre Drinker
- ArentFox Schiff
- Arnold & Porter
- ArentFox Schiff LLP
- Martin S. Rapaport
- Schulte Roth
- Debevoise & Plimpton
- Quinn Emanuel
- Saul Ewing
- Blitman & King
- Wilk Auslander
- Stutzman Bromberg
- Simpson Thacher & Bartlett LLP
- Akin Gump
- Stevens & Lee
- Napoli Shkolnik
- Robins Kaplan
- O'Brien Belland
- Marcus & Shapira
- Simmons Hanly
- Mintz Levin
- Shafferman & Feldman
- Hughes Socol
- Davis Polk
- Burke Warren
- O'Melveny & Myers
- Brown Rudnick
- Barack Ferrazzano
- Kleinberg Kaplan
- Levenfeld Pearlstein
- Rothstein Mandell
- MacElree Harvey
- Carter Ledyard
- Taft Stettinius
- Seyfarth Shaw
- Foley & Lardner
- Keller Postman
- Pullman & Comley
- Shook Hardy
- Tarter Krinsky
- Tate Law Group LLC
- Jones Day
- Lowey Dannenberg
- Kobre & Kim
- Goodwin Procter
- Wachtell Lipton
- Waldrep Wall
- Ifrah Law
- Seward & Kissel
- White Coleman & Associates
- Williams Mullen
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- White & Case
- Willkie Farr
Companies
- Teamsters Local 456
- Impax Laboratories, Inc.
- Henry Schein Inc.
- Sun Pharmaceutical Industries Ltd.
- CVS Health Corp.
- Hikma Pharmaceuticals PLC
- Province LLC
- Sandoz International GmbH
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Aleutian Pribilof Islands Association Inc.
- Blue Cross Blue Shield Association
- Collegium Pharmaceutical Inc.
- Walmart Inc.
- Houlihan Lokey Inc.
- Omnicare Inc.
- Endo International PLC
- Tucson Medical Center
- United Parcel Service Inc.
- Anda Inc.
- Avrio Health LP
- Hain Capital Group LLC
- AXA XL Ltd.
- KVK Tech Inc.
- Amneal Pharmaceuticals Inc.
- Johnson & Johnson
- TR Capital Management LLC
- Ironshore Inc.
- Express Scripts Holding Co.
- The Cigna Group
- Noramco Inc.
- FTI Consulting Inc.
- AlixPartners LLP
- Alaska Native Tribal Health Consortium
- Viatris Inc.
- DuPont de Nemours Inc.
- Allergan PLC
- Cencora Inc.
- Old Republic Insurance Co.
- Purdue Pharma LP
- Thermo Fisher Scientific Inc.
- United Food & Commercial Workers International Union
- Bausch Health Cos. Inc.
- Nardello & Co. LLC
- Oracle Corp.
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- McKesson Corp.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Otis Worldwide Corp.
- Loblaw Cos.
- Giant Eagle Inc.
- Verita Global LLC
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Seldovia Village Tribe
- Missouri Department of Revenue
- Pala Band of Mission Indians
- Town of Ramapo, New York
- Pension Benefit Guaranty Corp.
- Tennessee Attorney General's Office
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- State of Indiana
- Port Gamble S'Klallam Tribe
- Nez Perce Tribe
- Borough of Paramus, New Jersey
- Jamestown S'Klallam Tribe
- Northwestern Band of the Shoshone Nation
- Commonwealth of Massachusetts
- New York Department of Financial Services
- Town of Babylon, New York
- Town of Brookhaven, New York
- U.S. District Court for the District of Columbia
- Town of Hempstead, New York
- Hopi Tribe
- St. Regis Mohawk Tribe
- Suquamish Tribe
- State of Nevada
- Ohio Attorney General's Office
Sectors & Industries:
-
August 27, 2021
Sacklers Agree To Forgo Non-Opioid Ch. 11 Releases
Purdue Pharma told a New York bankruptcy judge on Friday that its owners in the Sackler family will no longer be getting releases for non-opioid liability, but liability immunity related to opioid claims will remain, as the hearing on the final decision on its Chapter 11 plan has been postponed.
-
August 25, 2021
Purdue Ch. 11 Judge Says Sackler Releases Should Be Tighter
A New York bankruptcy judge on Wednesday urged Purdue Pharma to narrow the nonopioid liability releases it is granting members of its owning Sackler family as he prepared to make his judgment on Purdue's Chapter 11 plan on Friday.
-
August 23, 2021
No More Speeches, Settle This Ch. 11, Purdue Judge Urges
Telling the parties Monday that "the time has passed at this point to speechify," the New York bankruptcy judge overseeing Purdue Pharma's bankruptcy urged the objecting states and the owning members of the Sackler family to settle their differences before the confirmation hearing resumes Wednesday.
-
August 19, 2021
Judge Urges Attention To Individual Stories In Purdue Ch. 11
The sixth day of evidence in Purdue Pharma's Chapter 11 plan confirmation hearing ended Thursday with the judge walking off camera after a declaration that the damage individuals have suffered in the opioid crisis should not be lost in the complexities of the bankruptcy case.
-
August 18, 2021
Ex-Purdue Chair Denies Blame For Opioid Crisis
A former president and board chairman of Purdue Pharma on Wednesday denied that the company or its owners in the Sackler family bore responsibility for the United States' opioid crisis as the confirmation hearing for Purdue's Chapter 11 plan entered its fifth day.
-
August 17, 2021
Sacklers Say They'll Fight Any Attempt To Foil Ch. 11 Releases
A member of the Purdue Pharma-owning Sackler family told a New York bankruptcy judge Tuesday that his family will not settle opioid claims without the releases in the company's proposed Chapter 11 plan and promised protracted fights against attempts to seek damages outside of bankruptcy.
-
August 16, 2021
Sackler Reps Say They Can't Sell Assets Without Releases
The liability releases for Purdue Pharma-owning members of the Sackler family in its Chapter 11 plan must stand in order for a court in the British Crown dependency of Jersey to release assets needed to fund the $4.5 billion settlement at its center, family representatives told a New York bankruptcy court Monday.
-
August 13, 2021
Sacklers' Ch. 11 Releases Are Fair, Supporting States Say
States and other government bodies that consented to Purdue Pharma's Chapter 11 plan defended the plan's liability releases for members of the Sackler family as the confirmation trial entered its second day Friday, arguing that it's a fair deal to fund opioid abatement.
-
August 12, 2021
Purdue's Ch. 11 Trial Opens With Attacks On Sackler Releases
States took immediate aim at Purdue Pharma's Chapter 11 plan letting members of the Sackler family off the hook for liability, asking at the two-week confirmation trial that kicked off in New York bankruptcy court Thursday if the company had looked at all the alternatives.
-
August 09, 2021
Purdue Allotted 10 Days For Ch. 11 Confirmation Trial
OxyContin maker Purdue Pharma's Chapter 11 plan confirmation trial will be limited to 10 days, after a New York bankruptcy judge said Monday that objectors to the plan had requested far too much time to cross-examine the debtor's fact and expert witnesses.